Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer Risk clinical trials
7 of 8 indexed Cancer Risk trials are currently recruiting.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 7 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Cancer Risk: 8 US clinical trials tracked, 7 recruiting.
Cancer Risk is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. The most active sponsor is Morehouse School of Medicine, running 1 of these trials.
Enrollment posture brief
Registry condition cancer-risk
OPEN 7 | RECR 88% | LATE 0 | EARLY 0 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Diseases (88% recruiting · 8 trials)
Cancer Risk lists 7 open slots (88% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cancer Risk on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer Risk is recruiting above its size-band peers.
7 of 8 indexed trials (87.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Cancer Risk trials is spread across many organizations.
Morehouse School of Medicine accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Cancer Risk enrolment sits around 10,000 participants.
Median target enrolment is 10,000 among the 8 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.
-
Cancer Risk research leans observational.
2 interventional and 6 observational studies make up this index (25% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
New Mexico Cancer Research Alliance
NCT03977402
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
University of Colorado, Denver
NCT03617939
Norris ORIEN Total Cancer Care
University of Southern California
NCT02970045
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
Hackensack Meridian Health
NCT06804395
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Dana-Farber Cancer Institute
NCT05463796
Morehouse Total Cancer Care Protocol
Morehouse School of Medicine
NCT04804878
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
University of California, San Francisco
NCT07121972
Cancer PRevention Through Enhanced EnvironMenT
University of Alabama at Birmingham
NCT06864260
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Cancer Risk records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cancer Risk trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cancer Risk page
8 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Cancer Risk trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Morehouse School of Medicine sponsors the most Cancer Risk trials on record, review their full trial history before evaluating a specific study. See Morehouse School of Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cancer Risk condition card totals 8 registered trials; most-linked intervention Medical Chart Review; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.